Kim HS - Search Results

1

Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium.

Verma SS, Bergmeijer TO, Gong L, Reny JL, Lewis JP, Mitchell BD, Alexopoulos D, Aradi D, Altman RB, Bliden K, Bradford Y, Campo G, Chang K, Cleator JH, Déry JP, Dridi NP, Fernandez-Cadenas I, Fontana P, Gawaz M, Geisler T, Gensini GF, Giusti B, Gurbel PA, Hochholzer W, Holmvang L, Kim EY, Kim HS, Marcucci R, Montaner J, Backman JD, Pakyz RE, Roden DM, Schaeffeler E, Schwab M, Shin JG, Siller-Matula JM, Ten Berg JM, Trenk D, Valgimigli M, Wallace J, Wen MS, Kubo M, Lee MTM, Whaley R, Winter S, Klein TE, Shuldiner AR, Ritchie MD; ICPC Investigators. Verma SS, et al. Among authors: kim ey, kim hs. Clin Pharmacol Ther. 2020 Nov;108(5):1067-1077. doi: 10.1002/cpt.1911. Epub 2020 Jul 9. Clin Pharmacol Ther. 2020. PMID: 32472697 Free PMC article.

2

The effect of ABCG2 V12M, Q141K and Q126X, known functional variants in vitro, on the disposition of lamivudine.

Kim HS, Sunwoo YE, Ryu JY, Kang HJ, Jung HE, Song IS, Kim EY, Shim JC, Shon JH, Shin JG. Kim HS, et al. Among authors: kim ey. Br J Clin Pharmacol. 2007 Nov;64(5):645-54. doi: 10.1111/j.1365-2125.2007.02944.x. Epub 2007 May 17. Br J Clin Pharmacol. 2007. PMID: 17509035 Free PMC article.

3

Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.

Kim HS, Lee SS, Oh M, Jang YJ, Kim EY, Han IY, Cho KH, Shin JG. Kim HS, et al. Among authors: kim ey. Pharmacogenet Genomics. 2009 Feb;19(2):103-12. doi: 10.1097/FPC.0b013e32831a9ae3. Pharmacogenet Genomics. 2009. PMID: 19077919

4

LC-MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: Basal plasma concentrations and aspirin-induced changes of eicosanoids.

Shinde DD, Kim KB, Oh KS, Abdalla N, Liu KH, Bae SK, Shon JH, Kim HS, Kim DH, Shin JG. Shinde DD, et al. Among authors: kim dh, kim kb, kim hs. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Dec 12;911:113-21. doi: 10.1016/j.jchromb.2012.11.004. Epub 2012 Nov 10. J Chromatogr B Analyt Technol Biomed Life Sci. 2012. PMID: 23217314

5

Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals.

Jiang F, Yeo CW, Lee SS, Oh MK, Ghim JL, Shon JH, Kim HS, Kim EY, Kim DH, Shin JG. Jiang F, et al. Among authors: kim ey, kim dh, kim hs. Pharmacogenet Genomics. 2013 Mar;23(3):175-9. doi: 10.1097/FPC.0b013e32835de25e. Pharmacogenet Genomics. 2013. PMID: 23292115

6

Different effects of clopidogrel and clarithromycin on the enantioselective pharmacokinetics of sibutramine and its active metabolites in healthy subjects.

Shinde DD, Kim HS, Choi JS, Pan W, Bae SK, Yeo CW, Shon JH, Kim DH, Shin JG. Shinde DD, et al. Among authors: kim dh, kim hs. J Clin Pharmacol. 2013 May;53(5):550-8. doi: 10.1002/jcph.69. Epub 2013 Feb 4. J Clin Pharmacol. 2013. PMID: 23381968 Clinical Trial.

7

Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients.

Kim KM, Kim HS, Lim SH, Cheong SH, Choi EJ, Kang H, Choi HR, Jeon JW, Yon JH, Oh M, Shin JG. Kim KM, et al. Among authors: kim hs. Int J Clin Pharmacol Ther. 2013 May;51(5):383-92. doi: 10.5414/CP201824. Int J Clin Pharmacol Ther. 2013. PMID: 23557865 Clinical Trial.

8

Impact of the CYP2C19*17 polymorphism on the clinical outcome of clopidogrel therapy in Asian patients undergoing percutaneous coronary intervention.

Park MW, Her SH, Kim HS, Choi YS, Park CS, Koh YS, Park HJ, Kim PJ, Kim CJ, Jeon DS, Shin DI, Seo SM, Yoo KD, Kim DB, Kim HY, Lee JM, Chung WS, Seung KB, Shin JG, Chang K. Park MW, et al. Among authors: kim hy, kim cj, kim pj, kim hs, kim db. Pharmacogenet Genomics. 2013 Oct;23(10):558-62. doi: 10.1097/FPC.0b013e328364eb92. Pharmacogenet Genomics. 2013. PMID: 23922007

9

The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects.

Kim HS, Kim GY, Yeo CW, Oh M, Ghim JL, Shon JH, Kim EY, Kim DH, Shin JG. Kim HS, et al. Among authors: kim gy, kim ey, kim dh. Br J Clin Pharmacol. 2014 May;77(5):821-30. doi: 10.1111/bcp.12236. Br J Clin Pharmacol. 2014. PMID: 24001154 Free PMC article. Clinical Trial.

10

CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina.

Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh M, Kim EY, Shon JH, Shin JG, Seung KB. Kim HS, et al. Among authors: kim ey. Circ Cardiovasc Genet. 2013 Oct;6(5):514-21. doi: 10.1161/CIRCGENETICS.113.000109. Epub 2013 Sep 9. Circ Cardiovasc Genet. 2013. PMID: 24019397 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,665 results

Search Page